Retinal thickness correlates with parietal cortical atrophy in early‐onset Alzheimer's disease and controls

by Jurre denHaan, Sarah F. Janssen, Jacoba A. van deKreeke, Philip Scheltens, Frank D. Verbraak, Femke H. Bouwman
Published 2018-01-01

Is retinal vasculature a biomarker in amyloid proven Alzheimer's disease?

by Jurre denHaan, Jacoba A. van deKreeke, Bart N. vanBerckel, Frederik Barkhof, Charlotte E. Teunissen, Philip Scheltens, Frank D. Verbraak, Femke H. Bouwman
Published 2019-12-01

Optical coherence tomography to measure the progression of myelopathy in adrenoleukodystrophy

by Wouter J. C. vanBallegoij, Irene C. Huffnagel, Stephanie I. W. van deStadt, Henry C. Weinstein, Carlien A. M. Bennebroek, Marc Engelen, Frank D. Verbraak
Published 2021-05-01

The spatial relation of diabetic retinal neurodegeneration with diabetic retinopathy.

by Jacoba A van de Kreeke, Stanley Darma, Jill M P L Chan Pin Yin, H Stevie Tan, Michael D Abramoff, Jos W R Twisk, Frank D Verbraak
Published 2020-01-01

Reduction of anterior uveitis flares in patients with axial spondyloarthritis on certolizumab pegol treatment: final 2-year results from the...

by Irene E. van der Horst-Bruinsma, Rianne E. van Bentum, Frank D. Verbraak, Atul Deodhar, Thomas Rath, Bengt Hoepken, Oscar Irvin-Sellers, Karen Thomas, Lars Bauer, Martin Rudwaleit
Published 2021-03-01

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

by Jurre den Haan, Tjado H. J. Morrema, Frank D. Verbraak, Johannes F. de Boer, Philip Scheltens, Annemieke J. Rozemuller, Arthur A. B. Bergen, Femke H. Bouwman, Jeroen J. Hoozemans
Published 2018-12-01

The impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis: 48-week interim results from C-VIEW

by Martin Rudwaleit, James T Rosenbaum, Irene van der Horst-Bruinsma, Maria Misterska-Skora, Rianne van Bentum, Frank D Verbraak, Thomas Rath, Bengt Hoepken, Oscar Irvin-Sellers, Brenda VanLunen, Lars Bauer
Published 2020-05-01

Ocular biomarkers for cognitive impairment in nonagenarians; a prospective cross-sectional study

by Jacoba A. van de Kreeke, Nienke Legdeur, Maryam Badissi, H. Ton Nguyen, Elles Konijnenberg, Jori Tomassen, Mara ten Kate, Anouk den Braber, Andrea B. Maier, H. Stevie Tan, Frank D. Verbraak, Pieter Jelle Visser
Published 2020-04-01

Retinal thickness as a potential biomarker in patients with amyloid‐proven early‐ and late‐onset Alzheimer's disease

by Jurre denHaan, Jacoba A. van deKreeke, Elles Konijnenberg, Mara tenKate, Anouk denBraber, Frederik Barkhof, Bart N. vanBerckel, Charlotte E. Teunissen, Philip Scheltens, Pieter Jelle Visser, Frank D. Verbraak, Femke H. Bouwman
Published 2019-12-01

Retinal thickness as potential biomarker in posterior cortical atrophy and typical Alzheimer’s disease

by Jurre den Haan, Lajos Csinscik, Tom Parker, Ross W. Paterson, Catherine F. Slattery, Alexander Foulkes, Femke H. Bouwman, Frank D. Verbraak, Philip Scheltens, Tunde Peto, Imre Lengyel, Jonathan M. Schott, Sebastian J. Crutch, Timothy J. Shakespeare, Keir X. X. Yong
Published 2019-07-01

The EMIF-AD PreclinAD study: study design and baseline cohort overview

by Elles Konijnenberg, Stephen F. Carter, Mara ten Kate, Anouk den Braber, Jori Tomassen, Chinenye Amadi, Linda Wesselman, Hoang-Ton Nguyen, Jacoba A. van de Kreeke, Maqsood Yaqub, Matteo Demuru, Sandra D. Mulder, Arjan Hillebrand, Femke H. Bouwman, Charlotte E. Teunissen, Erik H. Serné, Annette C. Moll, Frank D. Verbraak, Rainer Hinz, Neil Pendleton, Adriaan A. Lammertsma, Bart N. M. van Berckel, Frederik Barkhof, Dorret I. Boomsma, Philip Scheltens, Karl Herholz, Pieter Jelle Visser
Published 2018-08-01